New drug CBP-4888 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-phase study tested a new drug, CBP-4888, in 45 healthy women to see if it is safe and how the body processes it. Participants received either a single dose of the drug or a placebo, and researchers monitored for side effects like injection site pain or swelling. The go…
Phase: EARLY_PHASE1 • Sponsor: Comanche Biopharma • Aim: Knowledge-focused
Last updated May 17, 2026 13:56 UTC